Evaluation of preoperative intervention of duroxetin for postoperative residual pain

Evaluation of preoperative intervention of duroxetin for postoperative residual pain - Efficacy of duroxetin for postoperative residual pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034413

Enrollment

150

Registered

2021-12-01

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal disorders

Interventions

perioral duroxetin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who will receive spine surgery for a treatment of degenerative spinal disorder.

Exclusion criteria

Exclusion criteria: Patients having allergy for duroxetin

Design outcomes

Primary

Measure	Time frame
Patients' based evaluation	—

Countries

Japan

Contacts

Public ContactTakashi Hirai

Tokyo Medical and Dental University Department of Orthopeci Surgery

hirai.orth@tmd.ac.jp0358035279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026